BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15297725)

  • 1. [A systematic review of the clinical effectiveness of azathioprine in patients with ulcerative colitis].
    Ohno K; Masunaga Y; Ogawa R; Hashiguchi M; Ogata H
    Yakugaku Zasshi; 2004 Aug; 124(8):555-60. PubMed ID: 15297725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
    Timmer A; McDonald JW; Tsoulis DJ; Macdonald JK
    Cochrane Database Syst Rev; 2012 Sep; (9):CD000478. PubMed ID: 22972046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
    Timmer A; Patton PH; Chande N; McDonald JW; MacDonald JK
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD000478. PubMed ID: 27192092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis.
    Gisbert JP; Linares PM; McNicholl AG; Maté J; Gomollón F
    Aliment Pharmacol Ther; 2009 Jul; 30(2):126-37. PubMed ID: 19392869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
    Timmer A; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2007 Jan; (1):CD000478. PubMed ID: 17253451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2010 Jun; (6):CD000545. PubMed ID: 20556747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Prefontaine E; Sutherland LR; Macdonald JK; Cepoiu M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000067. PubMed ID: 19160175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
    Khan KJ; Dubinsky MC; Ford AC; Ullman TA; Talley NJ; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):630-42. PubMed ID: 21407186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azathioprine: state of the art in inflammatory bowel disease.
    Sandborn WJ
    Scand J Gastroenterol Suppl; 1998; 225():92-9. PubMed ID: 9515759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposing the weaknesses: a systematic review of azathioprine efficacy in ulcerative colitis.
    Leung Y; Panaccione R; Hemmelgarn B; Jones J
    Dig Dis Sci; 2008 Jun; 53(6):1455-61. PubMed ID: 17932752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis.
    Pearson DC; May GR; Fick GH; Sutherland LR
    Ann Intern Med; 1995 Jul; 123(2):132-42. PubMed ID: 7778826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease.
    Sandborn W; Sutherland L; Pearson D; May G; Modigliani R; Prantera C
    Cochrane Database Syst Rev; 2000; (2):CD000545. PubMed ID: 10796557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azathioprine maintains long-term steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis.
    Chebli LA; Chaves LD; Pimentel FF; Guerra DM; Barros RM; Gaburri PD; Zanini A; Chebli JM
    Inflamm Bowel Dis; 2010 Apr; 16(4):613-9. PubMed ID: 19705415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
    Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
    World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine.
    Matula S; Croog V; Itzkowitz S; Harpaz N; Bodian C; Hossain S; Ullman T
    Clin Gastroenterol Hepatol; 2005 Oct; 3(10):1015-21. PubMed ID: 16234048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine A for induction of remission in severe ulcerative colitis.
    Shibolet O; Regushevskaya E; Brezis M; Soares-Weiser K
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004277. PubMed ID: 15674937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
    Chande N; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006774. PubMed ID: 18425969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vedolizumab for induction and maintenance of remission in ulcerative colitis.
    Bickston SJ; Behm BW; Tsoulis DJ; Cheng J; MacDonald JK; Khanna R; Feagan BG
    Cochrane Database Syst Rev; 2014 Aug; (8):CD007571. PubMed ID: 25105240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.